How Long Is Long COVID? Evaluation of Long-Term Health Status in Individuals Discharged from a Specialist Community Long COVID Service.
Bodey, Rochelle, Grimaldi, Jennifer, Tait, Hannah et al. · Journal of clinical medicine · 2024 · DOI
Quick Summary
This study followed people who had received specialist care for long COVID and were then discharged from the service. Nearly 3 years after their initial COVID infection, most patients (90%) still had long COVID symptoms and hadn't returned to their normal health. About 4 in 10 of these patients also met the criteria for ME/CFS, suggesting long COVID can develop into a lasting condition similar to ME/CFS.
Why It Matters
This study provides important real-world evidence that a substantial proportion of long COVID patients experience persistent, disabling symptoms years after infection, with significant overlap with ME/CFS diagnostic criteria. Understanding this trajectory and overlap helps validate the chronic nature of post-COVID illness and supports the need for specialized, long-term management approaches for this population.
Observed Findings
90.2% of discharged patients (n=101/112) continued to experience long COVID symptoms and disability an average of 37.6 months post-infection
Mean EQ-5D-5L index score was 0.53 (SD 0.29), indicating severe disability across multiple life domains
43% of responding patients met NICE criteria for suspected ME/CFS
Average time from infection to study completion was 37.6 months; average time from service discharge to follow-up was 9.8 months
Only 9.8% of patients (n=11/112) reported return to pre-COVID-19 health status
Inferred Conclusions
A substantial proportion of long COVID patients develop persistent long COVID (PLC) that functions as a chronic long-term condition rather than resolving
There is significant clinical overlap between long COVID and ME/CFS, with nearly half of long COVID patients meeting diagnostic criteria for suspected ME/CFS
Specialist community-based long COVID services may help some patients but do not appear to produce full recovery in most cases
Remaining Questions
What factors predict which long COVID patients will develop persistent symptoms versus recover, and which will meet ME/CFS criteria?
Does the low response rate (24%) represent a systematic bias, and would findings differ significantly in non-responders or those still in services?
What This Study Does Not Prove
This study does not prove that long COVID causes ME/CFS or that they are the same condition—only that there is clinical overlap in symptoms. The low response rate (24%) may mean the findings overrepresent more severely affected patients who stayed engaged with services, so the actual proportion of long COVID patients developing persistent symptoms may differ in the broader population. The lack of a control group means we cannot determine what proportion of recovered long COVID patients might have similar disability levels.
Tags
Symptom:Cognitive DysfunctionPainFatigue
Phenotype:Infection-TriggeredLong COVID Overlap
Method Flag:PEM Not DefinedNo ControlsMixed Cohort
What specific interventions during specialist care were most associated with better long-term outcomes in the small proportion who did recover?
How do symptom patterns and ME/CFS overlap evolve over time—do patients' conditions stabilize, worsen, or improve beyond the follow-up period in this study?